AZACTAM is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Aztreonam.
Product ID | 0003-2570_461ef725-4364-41af-9e13-8365dc3f8b05 |
NDC | 0003-2570 |
Product Type | Human Prescription Drug |
Proprietary Name | AZACTAM |
Generic Name | Aztreonam |
Dosage Form | Injection, Powder, For Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 2010-04-01 |
Marketing Category | NDA / NDA |
Application Number | NDA050580 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | AZTREONAM |
Active Ingredient Strength | 2 g/1 |
Pharm Classes | Monobactam Antibacterial [EPC],Monobactams [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2010-04-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA050580 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-04-01 |
Ingredient | Strength |
---|---|
AZTREONAM | 2 g/1 |
SPL SET ID: | 9a105eaf-ee77-4016-beeb-d425a5565db2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0003-2230 | AZACTAM | AZTREONAM |
0003-2240 | AZACTAM | AZTREONAM |
0003-2560 | AZACTAM | AZTREONAM |
0003-2570 | AZACTAM | AZTREONAM |
0409-0829 | Aztreonam | Aztreonam |
0409-0830 | Aztreonam | Aztreonam |
63323-401 | Aztreonam | AZTREONAM |
63323-402 | Aztreonam | AZTREONAM |
61958-0901 | Cayston | aztreonam |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AZACTAM 73342064 1239150 Live/Registered |
E. R. Squibb & Sons, Inc. 1981-12-17 |